Jun 01, 2019 / Chapters

Appendix A: Commissioners’ voting on recommendations (June 2019 report)

Research Areas:

Beneficiaries and Coverage, Delivery System Reforms, Drugs, Devices, and Tests, Hospitals, Physicians And Other Health Professionals, Post-Acute Care, Private Plans, Quality, Regional Issues

Jun 01, 2019 / Chapters

Chapter 2: Restructuring Medicare Part D for the era of specialty drugs (June 2019 report)

Research Areas:

Delivery System Reforms, Drugs, Devices, and Tests, Medicare Spending and Financing

Apr 30, 2019 / Congressional Testimony

Testimony: Payment Policy for Prescription Drugs Under Medicare Part B and Part D (Energy and Commerce)

Research Areas:

Drugs, Devices, and Tests

Apr 05, 2019 / Presentations

Options to increase the affordability of specialty drugs and biologics in Medicare Part D

Research Areas:

Drugs, Devices, and Tests, Private Plans

Apr 05, 2019 / Comment Letters

MedPAC comment on OIG’s proposed rule on safe harbor regulation of prescription drug rebates

Research Areas:

Delivery System Reforms, Drugs, Devices, and Tests, Medicare Spending and Financing

Mar 15, 2019 / Reports

March 2019 Report to the Congress: Medicare Payment Policy

Research Areas:

Ambulatory Care Settings, Beneficiaries and Coverage, Delivery System Reforms, Drugs, Devices, and Tests, Hospitals, Medicare Spending and Financing, Physicians And Other Health Professionals, Post-Acute Care, Private Plans, Quality

Mar 15, 2019 / Fact Sheets

Fact sheet on MedPAC’s March 2019 Report to the Congress: Medicare Payment Policy

Research Areas:

Ambulatory Care Settings, Beneficiaries and Coverage, Delivery System Reforms, Drugs, Devices, and Tests, Hospitals, Medicare Spending and Financing, Physicians And Other Health Professionals, Post-Acute Care, Private Plans, Quality

Mar 15, 2019 / Press Releases

MedPAC releases March 2019 Report to the Congress: Medicare Payment Policy

Research Areas:

Ambulatory Care Settings, Beneficiaries and Coverage, Delivery System Reforms, Drugs, Devices, and Tests, Hospitals, Medicare Spending and Financing, Physicians And Other Health Professionals, Post-Acute Care, Private Plans, Quality

Mar 01, 2019 / Chapters

Chapter 14: The Medicare prescription drug program (Part D): Status report (March 2019 report)

Research Areas:

Drugs, Devices, and Tests

Mar 01, 2019 / Chapters

Chapter 16: Mandated report: Opioids and alternatives in hospital settings—Payments, incentives, and Medicare data (March 2019 report)

Research Areas:

Drugs, Devices, and Tests, Hospitals